InvestorsHub Logo

rosemountbomber

02/19/23 9:59 AM

#403663 RE: Nukemtiltheyglow #403662

And hopefully Nuke, since the FDA has seemingly relaxed their stance on AZ drugs, beneficial outcomes in some of these markers will get us a step closer to use if not approval. I still think the BRAVE study is not enough for any kind of approval, but it would be a stepping stone, and could fire up the stock price.